Nektar Therapeutics | NKTR - القيمة السوقية





القيمة السوقية تغيير تاريخ
Agios Pharmaceuticals USD 1.59B 745M 2025-12
ALKERMES USD 4.47B 146M 2026-03
Alterity Therapeutics Limited AUD 11M 5M 2023-06
Amgen USD 176.25B 24.32B 2025-12
Baxter International USD 9.82B 1.87B 2025-12
BioCryst Pharmaceuticals USD 1.7B 40M 2026-03
Biogen USD 25.82B 5.28B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Cara Therapeutics USD 28M 11M 2024-12
Cipla INR 1.22T 6.47B 2025-12
Dr.Reddys Laboratories INR 1.06T 39.78B 2025-12
Eisai JPY 1.4T 85.07B 2026-03
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 475M 410M 2026-03
Exelixis USD 11.75B 959M 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Grifols EUR 2.02B 4.34B 2026-03
Halozyme Therapeutics USD 7.91B 664M 2025-12
Incyte USD 19.39B 2.83B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
MacroGenics USD 192M 90M 2026-03
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 240.48B 51.73B 2026-03
Pfizer USD 153.96B 12.4B 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Teva Pharmaceutical Industries USD 36.42B 14.06B 2025-12
Xencor USD 1.09B 256M 2025-12